Responding to an investor query on whether MCX market share in commodity derivatives could slip to 75-80% over the next 3 -5 years, Praveena Rai, MD & CEO of MCX said, “We can make any prediction like that. I think we are certainly taking competition seriously. And not much headway has been made till now in terms of the competition for us to lose share. But, yes, we do respect the kind of efforts in the market, and I think overall it will help the market to grow….MCX will do whatever is required to be very competitive and hold our space here .”
